🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This clinical study compares the efficacy, safety, and tolerability of ther...
Status
Terminated
Location
UAB Dpt of Neurology
Start Date
2017-03-30
Trial ID
NCT02907177
Inflammatory synaptopathy is a prominent pathogenic process in multiple scl...
Status
Unknown
Location
IRCCS INM-Neuromed
Start Date
2023-07-26
Trial ID
NCT05779449
The primary objective of the study is to determine the effect of bismuth su...
Status
Completed
Location
Research Site
Start Date
2013-08
Trial ID
NCT01915901
To determine if treatment with BG00012 can decrease the number of MS relaps...
Status
Completed
Location
Research Site
Start Date
2007-06
Trial ID
NCT00451451
Treatments Being Tested
This study will evaluate the safety, tolerability, and pharmacokinetics of ...
Status
Completed
Location
Alkermes Investigational Site
Start Date
2014-07
Trial ID
NCT02201849
Treatments Being Tested
The primary objective of the study is to evaluate whether 150 mg enteric-co...
Status
Completed
Location
Research Site
Start Date
2014-05
Trial ID
NCT02090413
Treatments Being Tested
This multicenter, randomised, double-dummy, Fumaderm® and placebo-controlle...
Status
Withdrawn
Location
Probity Medical Research
Start Date
2016-06
Trial ID
NCT01815723
Treatments Being Tested
The purpose of this investigation is to systematically study the efficacy o...
Status
Completed
Location
Keck School of Medicine - USC - Department of Neurology
Start Date
2016-03-19
Trial ID
NCT02739542
The primary objective of the study is to assess whether a 6-week titration ...
Status
Terminated
Location
Research Site
Start Date
2015-04
Trial ID
NCT02428231
Treatments Being Tested
The primary objective of this study is to evaluate whether montelukast can ...
Status
Completed
Location
Research Site
Start Date
2015-03-12
Trial ID
NCT02410278
Treatments Being Tested